Clinical Trial Update: DOCE Study Interaction Between Direct Oral Anticoagulants and Drug-metabolizing Enzyme Inducers

View source ↗

Summary

This clinical trial update describes the DOCE study, which is examining potential interactions between direct oral anticoagulants and drug-metabolizing enzyme i…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atrial Fibrillation
• Venous Thromboembolism

Drugs mentioned

• Eliquis (apixaban)
• Pradaxa (dabigatran etexilate)
• Savaysa / Lixiana (edoxaban)
• Xarelto (rivaroxaban)

Snippet

Sponsor: Fondazione Policlinico Universitario Agostino Gemelli IRCCS | Conditions: Atrial Fibrillation, Thromboembolism, Venous | Status: ACTIVE_NOT_RECRUITING